Move over mascara: FDA approves eyelash growth drug

Washington, D.C. - The FDA has approved the first drug to promote eyelash growth. It's called Latisse. According to Allergan, the company that makes Latisse, the drug will go on sale early this coming year.

Latisse is available by prescription.

Latisse gets dabbed along the lash line on the upper eyelids to promote longer, thicker, darker lashes.

Allergan states that "Latisse users can expect to experience longer, fuller, and darker eyelashes in as little as eight weeks, with full results in 16 weeks." If Latisse is stopped, eyelashes will gradually return to their previous appearance as new eyelashes grow in.

Another side effect? Latisse may also promote hair growth in other skin areas that it frequently touches. Allergan recommends blotting it off any skin other than the upper eyelid's lash line to prevent that side effect.